SCHEMBL7668189

SCHEMBL7668189

Cc1ccc(-c2nc(S(=O)(=O)c3ccc(Cl)cc3)c(N(C)C)o2)cc1

nearest known ligand 0.88

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.88
KMT2A Q03164 2/20 0.88
NPC1 O15118 1/20 0.88
MAPT P10636 7/20 0.80
TDP1 Q9NUW8 2/20 0.80
ALDH1A1 P00352 7/20 0.65
XPO1 O14980 1/20 0.65
HTT P42858 1/20 0.65
KDM4E B2RXH2 3/20 0.64
THRB P10828 1/20 0.61
TSHR P16473 3/20 0.60
TP53 P04637 2/20 0.54
HPGD P15428 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
POLB P06746 1/20 0.50
MAPK1 P28482 1/20 0.50
HSD17B10 Q99714 2/20 0.49
PKM P14618 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6823671 0.87 MEN1 (0.87) MEN1KMT2ANPC1MAPTTDP1
SCHEMBL7670728 0.83 MEN1 (0.65) MEN1KMT2ANPC1MAPTTDP1
SCHEMBL25009628 0.81 MAPT (0.80) MEN1KMT2ANPC1MAPTTDP1
SCHEMBL25010448 0.80 ALDH1A1 (0.77) MEN1KMT2ANPC1MAPTTDP1
SCHEMBL25009644 0.79 TP53 (0.64) MEN1KMT2ANPC1MAPTTDP1
SCHEMBL7669614 0.79 MAPT (0.82) MEN1KMT2ANPC1MAPTTDP1
SCHEMBL25009171 0.77 MAPT (0.65) MEN1KMT2ANPC1MAPTTDP1
SCHEMBL25009351 0.77 ALDH1A1 (0.67) MEN1KMT2ANPC1MAPTALDH1A1
SCHEMBL25009348 0.75 MAPT (0.67) MEN1KMT2AMAPTALDH1A1HTT
SCHEMBL25009353 0.75 MAPT (0.66) MEN1KMT2ANPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002100842-A1 SULFONYLOXAZOLAMINES AND THEIR USE AS 5-HT6 LIGANDS MERCK PATENT GMBH (DE) 2002-12-19 WO disclosed
US-6441013-B1 5-HT6 RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS MERCK PATENT GMBH (DE) 2002-08-27 US disclosed
EP-1140875-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GmbH (DE) 2001-10-10 EP disclosed
WO-2000037452-A1 SULPHONYLOXAZOLAMINES AS THERAPEUTIC ACTIVE INGREDIENTS MERCK PATENT GMBH (DE) 2000-06-29 WO disclosed